Flow Pharma engineers and manufactures state-of-the-art medicines.
Our unique patented delivery system and biotechnology are ideally suited for curative intervention in cancer and viral disease.
A inhaled treatment to prevent COVID-19 disease in both virus-exposed and healthy patient populations.
FlowVax Ebola & Marburg
Marburg is a weaponized Ebola-like virus. By stimulating T-cells to target this virus, long-lasting infection prevention is attainable.
A revolutionary T-cell biomedicine that provides new hope for those with treatment-resistant, triple-negative breast cancer.